Literature DB >> 6090855

Incorporation of arachidonic acid and eicosapentaenoic acid into phospholipids by polymorphonuclear leukocytes in vitro.

J S Tou.   

Abstract

The present study demonstrated that the patterns of the incorporation of [1-14C] arachidonic acid and [1-14C] eicosapentaenoic acid into individual phospholipids by polymorphonuclear leukocytes were similar. However, human leukocytes exhibited higher activity than guinea pig peritoneal leukocytes in the formation of arachidonoyl- and eicosapentaenoyl-phosphatidic acid. Cells from both origins showed a decrease of label in phosphatidylcholine accompanied by an increase of label in phosphatidylethanolamine after a longer period (30-120 min) of incubation, suggesting that part of the arachidonoyl or eicosapentaenoyl moiety in phosphatidylethanolamine may be derived from that of phosphatidylcholine. The observed difference between human cells and elicited cells in the timecourse of the incorporation of both fatty acids into phosphatidylcholine and phosphatidylethanolamine appears to be due to different contents of the diacyl and ether-linked class compositions of these phospholipids in cells from different origins. Both labeled fatty acids were incorporated more rapidly into the diacyl-linked class, but were retained to a greater extent in alkylacyl-phosphatidylcholine and alkenylacyl-phosphatidylethanolamine. The data suggest that, in addition to alkylacylphosphatidylcholine and phosphatidylinositol, alkenylacyl-phosphatidylethanolamine may be an important endogenous source of arachidonic acid and eicosapentaenoic acid in stimulated human leukocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090855     DOI: 10.1007/bf02534713

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  Modulation of 32Pi incorporation into phospholipids of polymorphonuclear leukocytes by ionophore A23187.

Authors:  J S Tou
Journal:  Biochim Biophys Acta       Date:  1978-11-22

2.  Fatty acid and glycerol labeling of glycerolipids of leukocytes in response to ionophore A23187.

Authors:  J S Tou
Journal:  Biochim Biophys Acta       Date:  1979-02-26

3.  Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine.

Authors:  R M Kramer; D Deykin
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

4.  Acyltransferase-catalyzed cleavage of arachidonic acid from phospholipids and transfer to lysophosphatides in lymphocytes and macrophages.

Authors:  J Trotter; I Flesch; B Schmidt; E Ferber
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

5.  Fatty chains of acyl, alkenyl, and alkyl phosphoglycerides of rabbit sarcoplasmic reticulum. The metabolic relationship considered on the basis of structural analyses.

Authors:  K Waku; H Ito; T Bito; Y Nakazawa
Journal:  J Biochem       Date:  1974-06       Impact factor: 3.387

6.  Density heterogeneity of neutrophilic polymorphonuclear leukocytes: gradient fractionation and relationship to chemotactic stimulation.

Authors:  S O Pember; K C Barnes; S J Brandt; J M Kinkade
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

7.  Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.

Authors:  D W Goldman; W C Pickett; E J Goetzl
Journal:  Biochem Biophys Res Commun       Date:  1983-11-30       Impact factor: 3.575

8.  Ether phospholipids in guinea pig polymorphonuclear leukocytes and macrophages. Occurrence of high levels of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine.

Authors:  T Sugiura; Y Onuma; N Sekiguchi; K Waku
Journal:  Biochim Biophys Acta       Date:  1982-09-14

9.  Mechanism of arachidonic acid release in human polymorphonuclear leukocytes.

Authors:  C E Walsh; L R Dechatelet; F H Chilton; R L Wykle; M Waite
Journal:  Biochim Biophys Acta       Date:  1983-01-07

10.  Biochemical properties of polymorphonuclear neutrophils from venous blood and peritoneal exudates of rabbits.

Authors:  K Takamori; T Yamashita
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  9 in total

Review 1.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

2.  The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids.

Authors:  R C Baybutt; J E Smith; Y Y Yeh
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

3.  Platelet-activating factor modulates phospholipid acylation in human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

4.  Platelet-activating factor regulates phospholipid metabolism in human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

5.  Potential phospholipid source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil.

Authors:  F H Chilton
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

6.  In vitro effects of omega-3 fatty acids on neutrophil intracellular calcium homeostasis and receptor expression for FMLP and LTB4.

Authors:  K Georgilis; M S Klempner
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

Review 7.  Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid.

Authors:  F H Chilton; M Cluzel; M Triggiani
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

8.  Time course of incorporation of 20-carbon polyunsaturated fatty acids in a human keratinocyte cell line.

Authors:  K Punnonen; T Puustinen; C T Jansén
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

9.  Acylation of docosahexaenoic acid into phospholipids by intact human neutrophils.

Authors:  J S Tou
Journal:  Lipids       Date:  1986-05       Impact factor: 1.880

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.